OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
11.95
-0.25 (-2.05%)
May 20, 2025, 4:00 PM - Market closed
OptimizeRx Employees
As of December 31, 2024, OptimizeRx had 129 total employees, including 128 full-time and 1 part-time employees. The number of employees decreased by 7 or -5.15% compared to the previous year.
Employees
129
Change (1Y)
-7
Growth (1Y)
-5.15%
Revenue / Employee
$731,512
Profits / Employee
-$119,457
Market Cap
221.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
OPRX News
- 5 days ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - GlobeNewsWire
- 19 days ago - OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - GlobeNewsWire
- 4 weeks ago - OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - GlobeNewsWire
- 4 weeks ago - OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - GlobeNewsWire
- 2 months ago - OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
- 2 months ago - OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript - Seeking Alpha